UK markets closed

Ocugen, Inc. (OCGN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.40000.0000 (0.00%)
At close: 04:00PM EDT
0.4000 0.00 (0.00%)
After hours: 06:41PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.4000
Open0.4010
Bid0.3997 x 900
Ask0.4029 x 1000
Day's range0.3981 - 0.4029
52-week range0.3900 - 2.0890
Volume1,028,498
Avg. volume4,007,333
Market cap102.596M
Beta (5Y monthly)3.70
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Ocugen (OCGN) Q2 2023 Earnings Call Transcript

    Joining me today are Ocugen's Chairman, CEO, and Co-Founder Dr. Shankar Musunuri, who will provide a business and financial update; and Dr. Arun Upadhyay, our financial scientific officer, head of research development and medical, who is also on the call to answer questions during the Q&A. Yesterday afternoon, we issued a press release detailing business and operational highlights for the second quarter of 2023.

  • Motley Fool

    Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

    Wall Street has high hopes for certain stocks over the coming 12 months. Two of them are biotech companies that took center stage during earlier days of the pandemic. Both companies raced to bring a coronavirus vaccine to market.

  • Motley Fool

    Ocugen (OCGN) Q1 2023 Earnings Call Transcript

    Joining me today are Ocugen's chairman, CEO and co-founder; Dr. Shankar Musunuri, who will provide a business update; and our chief financial officer and chief business officer, Quan Vu, who will provide a financial update. Earlier this morning, we issued a press release detailing business and operational highlights for the first quarter of 2023.